Akero Therapeutics, Inc.
Industry: Life Sciences ・ $AKRO on Nasdaq
Insider Sale
+$26,202
-1.23%
Shares
Shares Volume: 949 Shares
Average Share Price: $27.61
INSIDER
Yale Catriona
Chief Development Officer (Officer)
reported on Sep 5 2024
traded on Sep 3 2024
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 75,931 |
| PURCHASES/SALES 1Y | 0 / 7 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $216,690.96 |
| INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 2 |
| PURCHASES/SALES 1Y | 2 / 39 |
| P/S VALUE RATIO | 0.216 |
| AVERAGE SALE VALUE | $435,988.92 |
| COMPANY PREVIOUS TRADES |